News Summary
NeutralBruker returned to organic revenue growth in Q2 2026 with margin expansion and robust bookings (+10% organically in Scientific Instruments), but reported a $134.9M goodwill impairment and faced FX headwinds that reduced full-year guidance. Strategic investments in fusion superconductors, organ-on-chip platforms, and AI-driven R&D position the company for growth, though near-term risks include U.S. government research funding uncertainty and a cautious analyst split.
Red flags
- •Material goodwill impairment of $134.9M in Q2, signaling prior acquisition integration challenges
- •GAAP operating loss of $65.3M in Q2 despite reported earnings beat, raising quality-of-earnings concerns
- •FY2026 organic growth guidance lowered to 1-2% (from prior implied expectations) and FX tailwind cut from 1.5% to 0.5%
- •White House moves to take control of NIH grants creating uncertainty for key academic/government research customer base
- •Goldman Sachs maintains Sell rating; stock trading near mid-52-week levels despite analyst upgrade from Leerink, suggesting limited conviction
Funds Buying (3)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | % of Fund | QoQ | Status |
|---|---|---|---|---|---|---|---|
| Sachem Head Capital | Scott Ferguson | 2.9M | +2.9M | $175M | 3.6% | — | NEW |
| Viking Global | Andreas Halvorsen | 893K | +893K | $54M | 0.2% | — | NEW |
| Glenview Capital | Larry Robbins | 252K | +252K | $15M | 0.3% | — | NEW |
Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.
Portfolio Context
Where BRKR ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.
position #13 of this fund's book
- 10GDS Hldgs Ltd$261M
- 11Gildan Activewear Inc$188M
- 12GOLAR LNG LTD$180M
- 13Bruker Corp$175M
- 14STMicroelectronics N V$165M
- 15Bitdeer Technologies Group$153M
- 16Twilio Inc$128M
position #36 of this fund's book
- 33BAKER HUGHES COMPANY$27M
- 34ELEVANCE HEALTH INC FORMERLY$26M
- 35MICROCHIP TECHNOLOGY INC.$24M
- 36BRUKER CORP$15M
- 37NOVARTIS AG$14M
- 38DIGITALOCEAN HLDGS INC$13M
- 39PRIMO BRANDS CORPORATION$10M
Values are quarter-end position sizes. Shown only for funds where BRKR ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.
Insider Activity
| Name | Title | Type | Shares | Price | Value | Filed | Src |
|---|---|---|---|---|---|---|---|
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. | SELL | 2K | $52.87 | $0.11M | 2026-09-15 | ↗ |
| Pusch Wolfgang | President BMID Group | SELL | 3K | $56.90 | $0.20M | 2026-08-17 | ↗ |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. | SELL | 2K | $57.60 | $0.12M | 2026-08-14 | ↗ |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. | SELL | 2K | $60.25 | $0.12M | 2026-07-15 | ↗ |
Beneficial Ownership (13D/13G)
| Filer | Form | Shares | % of Class | Filed | Src |
|---|---|---|---|---|---|
| FMR LLC | SC 13G/A | 23.3M | 15.0% | 2026-08-06 | ↗ |
| ORBIS INVESTMENT MANAGEMENT LTD | SC 13G/A | 16.9M | 11.1% | 2026-05-15 | ↗ |
| FMR LLC | SC 13G/A | 19.2M | 12.4% | 2026-05-06 | ↗ |
SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.